Close
4
Promoted Content
Promoted Content

Company profile for Apeiron Biologics

Client EmailClient Virtual Booth
APEIRON BIOLOGICS
  • Connect with Us...

PharmaCompass
About the Company
APEIRON is a privately-held European biotech company based in Vienna, Austria, focused on the discovery and development of novel cancer immunotherapies. APEIRON received EU marketing approval for APN311 (Dinutuximab beta, Qarziba®) in May 2017 for the treatment of pediatric neuroblastoma patients and out-licensed global, exclusive rights to this product to EUSA Pharma Ltd. APEIRON now leverages its proprietary master checkpo...
APEIRON is a privately-held European biotech company based in Vienna, Austria, focused on the discovery and development of novel cancer immunotherapies. APEIRON received EU marketing approval for APN311 (Dinutuximab beta, Qarziba®) in May 2017 for the treatment of pediatric neuroblastoma patients and out-licensed global, exclusive rights to this product to EUSA Pharma Ltd. APEIRON now leverages its proprietary master checkpoint blockade mechanism to enable the human body’s natural defense mechanisms to fight tumors.
Upgrade the company profile

Upgrade this company profile// Update & customize all content.
Ask PharmaCompass, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Apeiron Biologics
Austria Flag
Country
Country
AUSTRIA
Address
Address
APEIRON Biologics AG Campus-Vienna-Biocenter 5 1030 Vienna
Telephone
Telephone
+43 1 86565 77
Linkedin
Linkedin
Twitter
Twitter
Client Virtual Booth

Upgrade this company profile// Update & customize all content.
Ask PharmaCompass, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Learn More About